Genmab A (GMAB) Goodwill & Intangibles (2018 - 2026)
Genmab A (GMAB) reported Goodwill & Intangibles of $9.3 billion for Q1 2026, up 340.69% on a YoY basis from $2.1 billion in Q1 2025, and down 1.85% quarter-over-quarter from $9.5 billion in Q4 2025.
Genmab A (GMAB) Goodwill & Intangibles (2018 - 2026) Analysis & Trends
Genmab A has reported Goodwill & Intangibles for 7 years, with the latest figure at $9.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles rose 340.69% year-over-year to $9.3 billion; the trailing twelve-month figure through Mar 2026 stood at $9.3 billion (up 340.69% YoY), and the FY2025 full-year result was $9.5 billion, up 355.02% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $9.3 billion, down from $9.5 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $9.5 billion in Q4 2025, with the low at $15.0 million in Q4 2023.
- Historically, Goodwill & Intangibles has averaged $3.9 billion across 4 years, with a median of $2.1 billion in 2025.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles soared 13786.67% — and 2026, when it surged 340.69%.
- Genmab A's Goodwill & Intangibles stood at $15.0 million in 2023, then soared by 13786.67% to $2.1 billion in 2024, then jumped by 355.02% to $9.5 billion in 2025, then declined by 1.85% to $9.3 billion in 2026.
- The last three Goodwill & Intangibles figures came in at $9.3 billion (Q1 2026), $9.5 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Genmab A | 48.34 Bn | 46.82 Bn | 831.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.30 Bn |
| Dec 31, 2025 | 9.48 Bn |
| Sep 30, 2025 | 2.10 Bn |
| Jun 30, 2025 | 2.11 Bn |
| Mar 31, 2025 | 2.11 Bn |
| Dec 31, 2024 | 2.08 Bn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2020 | 385.00 |
| Dec 31, 2019 | 470.00 |
| Sep 30, 2019 | 419.63 Mn |
| Dec 31, 2018 | 470.36 Mn |